Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 5.7B | 4.7B | 5.2B |
Cost of revenue | 2.7B | 3.3B | 2.6B | 3.1B |
Gross profit | 1.9B | 2.4B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 788.3M | 1.3B | 935.7M | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 452.5M | 434.6M | 398.8M | 422.7M |
Other income expense | 57.1M | 43.5M | 56.2M | 51.1M |
Pretax income | 392.9M | 918.7M | 593.1M | 645.1M |
Tax provision | 59.7M | 144.9M | 41.8M | 42.6M |
Net income | 333.2M | 773.8M | 551.4M | 602.5M |
Basic EPS | — | 0.9 | 0.6 | 0.7 |
Diluted EPS | — | 0.9 | 0.6 | 0.7 |
Basic average shares | — | 860.3M | 856.5M | 856.3M |
Diluted average shares | — | 860.3M | 861.5M | 860.7M |
EBITDA | 1.6B | 2.1B | 1.8B | 1.8B |
Net income from continuing op. | 334.1M | 773.8M | 551.4M | 602.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |